BMY Stock: It’s Time to Buy Bristol-Myers Squibb Co

Following a failed cancer drug approval, BMY stock dropped nearly 16%. That appears to be an overreaction, so time to take a bullish stance. More 

Why Bristol-Myers Squibb Co (BMY), Liberty Interactive Corp (QVCA) and Royal Bank of Scotland Group PLC (RBS) and Are 3 of Today’s Worst Stocks

Bristol-Myers (BMY), Liberty Interactive (QVCA) and Royal Bank of Scotland (RBS) never even had a chance of bullishness on Friday. More 

3 Big Stock Charts for Friday: Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK) and Fitbit Inc (FIT)

Huge news changes the technical outlook for Merck (MRK) and Bristol-Myers (BMY) while the long-term picture favors the bulls for Fitbit (FIT). More 

Can These 3 Big Pharma Stocks Pull Off an Earnings Surprise?

Although there have been some grumblings towards Big Pharma stocks, look for the stronger names to produce the winnings. More 

Trade of the Day: BMY Stock Triggers New Buy Signal

Bristol-Myers Squibb Co appears to be headed to new More 

Bull of the Day: Bristol-Myers Squibb Co (BMY)

Bristol-Myers Squibb (BMY) stock offers investors a nice combination of solid growth potential and a decent dividend yield. More 

3 Big Pharma Stocks Under the Microscope: BMY, ABBV, LLY

Are prevailing concerns about big pharma stocks taking their toll, or are LLY, BMY and ABBV showing their strength anyway? More